Camurus AB (CHIX:CAMXS) Tariff Resilience Score: 0/10 (As of Jul. 07, 2026)


CHIX:CAMXS Camurus AB CHIX:CAMXS
86 GF Score
Price kr564.00
GF Value kr691.22
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Camurus AB Tariff Resilience Score?

Camurus AB has the Tariff Resilience Score of 0, which implies that the company might have .

Camurus AB has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Camurus AB might have .

Camurus AB  (CHIX:CAMXs) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Camurus AB Tariff Resilience Score Related Terms

CHIX:CAMXS
86GF Score
Camurus AB CHIX:CAMXS
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Camurus AB (CHIX:CAMXS) Overvalued in 2026?

Based on GuruFocus' analysis, Camurus AB stock appears to be undervalued. The current stock price of kr564.00 is trading 18.4% below its estimated GF Value™ of kr691.22. GuruFocus considers Camurus AB to be Modestly Undervalued.

Key valuation signals for CHIX:CAMXS:

  • Tariff Resilience Score: 0
  • GF Value™: kr691.22 vs. price of kr564.00 (18.4% below fair value)
  • GF Score™: 86/100 with 1 warning sign

No single metric tells the full story. See the CHIX:CAMXS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Camurus AB Business Description

Address Rydbergs torg 4, Lund, SWE, SE-224 84
Camurus AB is a science-led biopharmaceutical company focused on developing and commercializing long-acting medicines for the treatment of severe and chronic diseases. It has two approved products, including treatments for opioid dependence, and a development pipeline supported by its FluidCrystal technology. Its clinical pipeline includes product candidates for conditions such as pain, cancer, endocrine, and metabolic diseases, developed in-house and in collaboration with international pharmaceutical companies. Its pipeline programs include CAM2029 for acromegaly, gastroenteropancreatic neuroendocrine tumors, and polycystic liver disease; CAM2038 for chronic pain; CAM4072 for genetic obesity disorders; CAM2043 for Raynaud's phenomenon; CAM4071 for endocrine disorders, among others.
86GF Score

Get the complete analysis for CHIX:CAMXS

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr564.00
Price
kr691.22
GF Value